Novel breast cancer treatment leads to hyperglycaemia.
Bass, I R
Novel breast cancer treatment leads to hyperglycaemia. [electronic resource] - Diabetic medicine : a journal of the British Diabetic Association 05 2020 - 893-894 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
1464-5491
10.1111/dme.14281 doi
Aged
Antineoplastic Agents, Hormonal--therapeutic use
Blood Glucose--metabolism
Blood Glucose Self-Monitoring
Breast Neoplasms--complications
Class I Phosphatidylinositol 3-Kinases--genetics
Female
Fulvestrant--therapeutic use
Humans
Hyperglycemia--chemically induced
Monitoring, Ambulatory
Phosphoinositide-3 Kinase Inhibitors--adverse effects
Prediabetic State--complications
Thiazoles--adverse effects
Novel breast cancer treatment leads to hyperglycaemia. [electronic resource] - Diabetic medicine : a journal of the British Diabetic Association 05 2020 - 893-894 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
1464-5491
10.1111/dme.14281 doi
Aged
Antineoplastic Agents, Hormonal--therapeutic use
Blood Glucose--metabolism
Blood Glucose Self-Monitoring
Breast Neoplasms--complications
Class I Phosphatidylinositol 3-Kinases--genetics
Female
Fulvestrant--therapeutic use
Humans
Hyperglycemia--chemically induced
Monitoring, Ambulatory
Phosphoinositide-3 Kinase Inhibitors--adverse effects
Prediabetic State--complications
Thiazoles--adverse effects